Invention Grant
- Patent Title: Amino-quinolines as kinase inhibitors
-
Application No.: US15811712Application Date: 2017-11-14
-
Publication No.: US10220030B2Publication Date: 2019-03-05
- Inventor: Michael Jonathan Bury , Linda N. Casillas , Adam Kenneth Charnley , Pamela A. Haile , Robert W. Marquis, Jr. , John F. Mehlmann , Joseph J. Romano , Robert R. Singhaus, Jr. , Gren Z. Wang
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Nora L. Stein; Fang Qian
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; C07D401/12 ; C07D405/14 ; C07D417/12 ; C07D215/44 ; C07D405/12 ; C07D417/14 ; C07D471/04 ; A61K31/4706
Abstract:
Disclosed are compounds having the formula: wherein R1, R2, R3 and Z are as defined herein, and methods of making and using the same.
Public/Granted literature
- US20180085365A1 AMINO-QUINOLINES AS KINASE INHIBITORS Public/Granted day:2018-03-29
Information query
IPC分类:
